Literature DB >> 28972140

A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.

Lucy C Sullivan1, Nicholas G Walpole2, Carine Farenc2, Gabriella Pietra3,4, Matthew J W Sum1, Craig S Clements2, Eleanor J Lee1, Travis Beddoe2, Michela Falco5, Maria Cristina Mingari3,4,6, Lorenzo Moretta5, Stephanie Gras2,7, Jamie Rossjohn8,7,9, Andrew G Brooks10.   

Abstract

αβ T cell receptors (TCRs) interact with peptides bound to the polymorphic major histocompatibility complex class Ia (MHC-Ia) and class II (MHC-II) molecules as well as the essentially monomorphic MHC class Ib (MHC-Ib) molecules. Although there is a large amount of information on how TCRs engage with MHC-Ia and MHC-II, our understanding of TCR/MHC-Ib interactions is very limited. Infection with cytomegalovirus (CMV) can elicit a CD8+ T cell response restricted by the human MHC-Ib molecule human leukocyte antigen (HLA)-E and specific for an epitope from UL40 (VMAPRTLIL), which is characterized by biased TRBV14 gene usage. Here we describe an HLA-E-restricted CD8+ T cell able to recognize an allotypic variant of the UL40 peptide with a modification at position 8 (P8) of the peptide (VMAPRTLVL) that uses the TRBV9 gene segment. We report the structures of a TRBV9+ TCR in complex with the HLA-E molecule presenting the two peptides. Our data revealed that the TRBV9+ TCR adopts a different docking mode and molecular footprint atop HLA-E when compared with the TRBV14+ TCR-HLA-E ternary complex. Additionally, despite their differing V gene segment usage and different docking mechanisms, mutational analyses showed that the TCRs shared a conserved energetic footprint on the HLA-E molecule, focused around the peptide-binding groove. Hence, we provide new insights into how monomorphic MHC molecules interact with T cells.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  T-cell receptor (TCR); major histocompatibility complex (MHC); mutagenesis; receptor structure-function; structural biology; viral immunology

Mesh:

Substances:

Year:  2017        PMID: 28972140      PMCID: PMC5743087          DOI: 10.1074/jbc.M117.807719

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules.

Authors:  W F Lo; H Ong; E S Metcalf; M J Soloski
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

3.  HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.

Authors:  Chiara Romagnani; Gabriella Pietra; Michela Falco; Paola Mazzarino; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Hum Immunol       Date:  2004-05       Impact factor: 2.850

Review 4.  The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.

Authors:  Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

Review 5.  The involvement of class Ib molecules in the host response to infection with Salmonella and its relevance to autoimmunity.

Authors:  M J Soloski; E S Metcalf
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

Review 6.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

7.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Authors:  Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

8.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

9.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

10.  Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.

Authors:  B M Baker; R V Turner; S J Gagnon; D C Wiley; W E Biddison
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  9 in total

1.  The murine CD94/NKG2 ligand, Qa-1b, is a high-affinity, functional ligand for the CD8αα homodimer.

Authors:  Katharine Jennifer Goodall; Angela Nguyen; Craig McKenzie; Sidonia Barbara Guiomar Eckle; Lucy Catherine Sullivan; Daniel Mark Andrews
Journal:  J Biol Chem       Date:  2020-01-28       Impact factor: 5.157

2.  HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection.

Authors:  David Tarragó; Irene González; Maria Francisca González-Escribano
Journal:  BMC Genomics       Date:  2022-06-20       Impact factor: 4.547

Review 3.  Antigen presentation by MHC-E: a putative target for vaccination?

Authors:  Linda Voogd; Paula Ruibal; Tom H M Ottenhoff; Simone A Joosten
Journal:  Trends Immunol       Date:  2022-03-31       Impact factor: 19.709

4.  Mobilizing unconventional T cells.

Authors:  Tom H M Ottenhoff; Simone A Joosten
Journal:  Science       Date:  2019-10-18       Impact factor: 47.728

Review 5.  Integrating Experiment and Theory to Understand TCR-pMHC Dynamics.

Authors:  Ashley M Buckle; Natalie A Borg
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

6.  Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral Blood.

Authors:  Elena I Kovalenko; Ivan V Zvyagin; Maria A Streltsova; Artem I Mikelov; Sofya A Erokhina; William G Telford; Alexander M Sapozhnikov; Yury B Lebedev
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

Review 7.  Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes.

Authors:  Antonio Arnaiz-Villena; Fabio Suarez-Trujillo; Ignacio Juarez; Carmen Rodríguez-Sainz; José Palacio-Gruber; Christian Vaquero-Yuste; Marta Molina-Alejandre; Eduardo Fernández-Cruz; José Manuel Martin-Villa
Journal:  Cell Mol Life Sci       Date:  2022-08-04       Impact factor: 9.207

8.  MHC Restriction: Where Are We Now?

Authors:  Pirooz Zareie; Carine Farenc; Nicole L La Gruta
Journal:  Viral Immunol       Date:  2020-04       Impact factor: 2.257

9.  Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognition.

Authors:  Claire Barber; Victoria Arena De Souza; Rachel L Paterson; Magdalena Martin-Urdiroz; Nitha Charles Mulakkal; Velupillai Srikannathasan; Mary Connolly; Gwilym Phillips; Tein Foong-Leong; Robert Pengelly; Vijaykumar Karuppiah; Tressan Grant; Marcin Dembek; Anil Verma; Dawn Gibbs-Howe; Thomas H Blicher; Andrew Knox; Ross A Robinson; David K Cole; Sarah Leonard
Journal:  Eur J Immunol       Date:  2022-02-13       Impact factor: 6.688

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.